Target intelligence / Profile preview

Protein pelota homolog (PELO)

Target
PELO
Molecular classification
Ribosome rescue factor, mRNA surveillance factor
01

Overview

Protein pelota homolog (PELO) is a highly conserved cytoplasmic protein, encoded by the PELO gene in humans[1][9]. It belongs to a family of proteins involved in the recognition and rescue of stalled ribosomes during translation, in a process known as ribosome quality control or No-Go Decay (NGD)[2][5][7]. PELO functions with partners such as HBS1L and ABCE1 to dismantle aberrant ribosome complexes, release nascent polypeptide-tRNA, and promote ribosome recycling independent of stop codon recognition[6]. In biological systems, PELO plays important roles in translational surveillance, cell cycle control, spermatogenesis, and adult stem cell self-renewal[1][3][4]. Loss of PELO function leads to defects in spermatogenesis and meiotic arrest in model organisms and can dysregulate translation of proteins critical in hematopoiesis (e.g., the C/EBPα isoform in myeloid cells), connecting PELO indirectly to cancer biology[4]. There is no current evidence that PELO is a direct therapeutic target or that drugs interact with it, and no established biomarker or specific safety concern for its targeting in humans.

Other names
PelotaDom34 homologCGI-17PELOTAPELO homologmRNA surveillance and ribosome rescue factor PELO
02

Biological functions

Ribosome rescuemRNA surveillance/quality controlTranslation regulationCell cycle regulationSpermatogenesisStem cell self-renewal
03

Disease associations

Cancer (regulation of translation in leukemogenesis, e.g., C/EBPα isoform shift)Potential infertility/defective spermatogenesis (in model organisms)Other (implicated in ribosome-related quality control diseases)

Beyond the preview

Go deeper on Protein pelota homolog (PELO).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein pelota homolog (PELO).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call